An on‐Demand Oxygen Nano‐vehicle Sensitizing Protein and Nucleic Acid Drug Augment Immunotherapy

S Sidi Zhang (State Key Laboratory of Systems Medicine for Cancer Shanghai Cancer Institute. Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200032 P. R. China) X Xinghui Wang (College of Physics and Information Engineering, Institute of Micro–Nano Devices and Solar Cells, Fuzhou University) X Xiaojing Chen D Duohuo Shu Q Quankun Lin (State Key Laboratory of Systems Medicine for Cancer Shanghai Cancer Institute. Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200032 P. R. China) H Hanbing Zou (State Key Laboratory of Systems Medicine for Cancer Shanghai Cancer Institute. Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200032 P. R. China) J Jialin Dong (Anshan Ziyu Laser Technology Co., Ltd. 4 , AnShan 114044,) B Bing Wang Q Qianyun Tang (State Key Laboratory of Systems Medicine for Cancer Shanghai Cancer Institute. Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200032 P. R. China) H Huishan Li (State Key Laboratory of Systems Medicine for Cancer Shanghai Cancer Institute. Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200032 P. R. China) X Xiaoxiang Chen J Jun Pu B Bin Gu P Peifeng Liu (State Key Laboratory of Systems Medicine for Cancer Shanghai Cancer Institute Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai P. R. China)

Abstract

Abstract Hypoxia severely limits the antitumor immunotherapy for breast cancer. Although efforts to alleviate tumor hypoxia and drug delivery using diverse nanostructures achieve promising results, the creation of a versatile controllable oxygen‐releasing nano‐platform for co‐delivery with immunostimulatory molecules remains a persistent challenge. To address this problem, a versatile oxygen controllable releasing vehicle PFOB@F127@PDA (PFPNPs) is developed, which effectively co‐delivered either protein drug lactate oxidase (LOX) or nucleic acids drug unmethylated cytosine‐phosphate‐guanine oligonucleotide (CpG ODNs). Upon photothermal heating, this platform triggered oxygen release, thereby augmenting LOX‐mediated lactate detection rates, and improving T cells infiltrating and cytokine expression. Moreover, under an oxygenated tumor microenvironment (TME), PFPNPs co‐delivered with CpG ODNs effectively reprogrammed the immunosuppressive TME by repolarizing macrophages to an M1‐like phenotype, promoting dendritic cells maturation, and increasing tumor‐infiltrating T cells while decreasing the ratio of regulatory T cells (Tregs). Our study demonstrated that this controlled oxygen‐releasing platform possessed adaptive drug‐loading capabilities to meet varied immunotherapeutic demands in clinical settings.

Article Details

Volume / Issue Vol. 37, Issue 9
Published March 01, 2025
ISSN 0935-9648
Publisher Unknown Publisher

Journal Info

Advanced Materials

Unknown Publisher

ISSN: 0935-9648 Physical Sciences

Authors (14)

S

Sidi Zhang

State Key Laboratory of Systems Medicine for Cancer Shanghai Cancer Institute. Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200032 P. R. China

X

Xinghui Wang

College of Physics and Information Engineering, Institute of Micro–Nano Devices and Solar Cells, Fuzhou University

X

Xiaojing Chen

D

Duohuo Shu

Q

Quankun Lin

State Key Laboratory of Systems Medicine for Cancer Shanghai Cancer Institute. Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200032 P. R. China

H

Hanbing Zou

State Key Laboratory of Systems Medicine for Cancer Shanghai Cancer Institute. Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200032 P. R. China

J

Jialin Dong

Anshan Ziyu Laser Technology Co., Ltd. 4 , AnShan 114044,

B

Bing Wang

Q

Qianyun Tang

State Key Laboratory of Systems Medicine for Cancer Shanghai Cancer Institute. Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200032 P. R. China

H

Huishan Li

State Key Laboratory of Systems Medicine for Cancer Shanghai Cancer Institute. Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200032 P. R. China

X

Xiaoxiang Chen

J

Jun Pu

B

Bin Gu

P

Peifeng Liu

State Key Laboratory of Systems Medicine for Cancer Shanghai Cancer Institute Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai P. R. China